Literature DB >> 23857623

Ulnar sensory-motor amplitude ratio: a new tool to differentiate ganglionopathy from polyneuropathy.

Raphael Ubirajara Garcia1, João Adilson Gama Ricardo, Cassiana Abreu Horta, Solange Garcia Garibaldi, Anamarli Nucci, Marcondes Cavalcante França.   

Abstract

UNLABELLED: The objective of this study was to evaluate if the ratio of ulnar sensory nerve action potential (SNAP) over compound muscle action potential (CMAP) amplitudes (USMAR) would help in the distinction between ganglionopathy (GNP) and polyneuropathy (PNP).
METHODS: We reviewed the nerve conductions studies and electromyography (EMG) of 18 GNP patients, 33 diabetic PNP patients and 56 controls. GNP was defined by simultaneous nerve conduction studies (NCS) and magnetic resonance imaging (MRI) abnormalities. PNP was defined by usual clinical and NCS criteria. We used ANOVA with post-hoc Tukey test and ROC curve analysis to compare ulnar SNAP and CMAP, as well as USMAR in the groups.
RESULTS: Ulnar CMAP amplitudes were similar between GNP x PNP x Controls (p=0.253), but ulnar SNAP amplitudes (1.6±3.2 x 11.9±9.1 × 45.7±24.7) and USMAR values (0.3±0.3 × 1.5±0.9 × 4.6±2.2) were significantly different. A USMAR threshold of 0.71 was able to differentiate GNP and PNP (94.4% sensitivity and 90.9% specificity).
CONCLUSIONS: USMAR is a practical and reliable tool for the differentiation between GNP and PNP.

Entities:  

Mesh:

Year:  2013        PMID: 23857623     DOI: 10.1590/0004-282X20130063

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  2 in total

1.  Spinal cord diffusion tensor imaging in patients with sensory neuronopathy.

Authors:  Raphael Fernandes Casseb; Jean Levi Ribeiro de Paiva; Lucas Melo Teixeira Branco; Alberto Rolim Muro Martinez; Fabiano Reis; José Carlos de Lima-Junior; Gabriela Castellano; Marcondes Cavalcante França Junior
Journal:  Neuroradiology       Date:  2016-08-25       Impact factor: 2.804

2.  Rapid neurophysiological screening for sensory ganglionopathy: A novel approach.

Authors:  Panagiotis Zis; Marios Hadjivassiliou; Ptolemaios Georgios Sarrigiannis; Alexander St John Edward Barker; Dasappaiah Ganesh Rao
Journal:  Brain Behav       Date:  2017-11-24       Impact factor: 2.708

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.